Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis

Journal of Clinical Investigation

Volumn 100, Issue 8, 1997, Pages 2035-2042

  Shears II, Larry L ^a   Kawaharada, Nobuyoshi ^a   Tzeng, Edith ^a   Billiar, Timothy R ^a   Watkins, Simon C ^b   Kovesdi, Imre ^c   Lizonova, Alena ^c   Pham, Si M ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c GENVEC INC   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Chronic rejection; Cyclosporine; Gene therapy; Intimal hyperplasia; Transplantation

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYSINE DERIVATIVE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VIRUS VECTOR;

ADENOVIRUS; ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME INDUCTION; GENE TRANSFER; GRAFT FAILURE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030727904     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119736     Document Type: Article

References (48)

1. Ardehali, A. 1995. Heart transplantation: accelerated graft atherosclerosis. Adv. Card. Surg. 6:195-205.
2. Ventura, H.O., F.W. Smart, D.D. Stapleton, T. Toups, and H.L. Price. 1993. Cardiac allograft vasculopathy: current concepts. J. La. State Med. Soc. 145:195-198.
3. Ventura, H.O., M.R. Mehra, F.W. Smart, and D.D. Stapleton. 1995. Cardiac allograft vasculopathy: current concepts. Am. Heart J. 129:791-799.
4. Kerber, S., A. Rahmel, O. Heinemann-Vechtel, T. Budde, M. Deng, H.H. Scheld, and G. Breithardt. 1995. Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation. Int. J. Cardiol. 49:119-129.
5. Mehra, M.R., H.O. Ventura, F.W. Smart, D.D. Stapleton, T.J. Collins, S.R. Ramee, J.P. Murgo, and C.J. White. 1995. New developments in the diagnosis and management of cardiac allograft vasculopathy. Tex. Heart Inst. J. 22: 138-144.
6. Gibbons, G.H. 1995. The pathogenesis of graft vascular disease: implications of vascular remodeling. J. Heart Lung Transplant. 14:S149-S158.
7. Mehra, M.R., H.O. Ventura, D.D. Stapleton, and F.W. Smart. 1995. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. J. Heart Lung Transplant. 14:S207-S211.
8. Tanaka, H., S.J. Swanson, G. Sukhova, F.J. Schoen, and P. Libby. 1995. Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A. Transplant. Proc. 27:2062-2065.
9. Russell, P.S., C.M. Chase, H.J. Winn, and R.B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am. J. Pathol. 144:260-274.
10. Russell, P.S., C.M. Chase, H.J. Winn, and R.B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J. Immunol. 152:5135-5141.
11. Russell, M.E. 1995. Macrophages and transplant arteriosclerosis: known and novel molecules. J. Heart Lung Transplant. 14:S111-S115.
12. Costanzo, M.R. 1995. The role of histoincompatibility in cardiac allograft vasculopathy. J. Heart Lung Transplant. 14:S180-S184.
13. Davis, S.F., A.C. Yeung, I.T. Meredith, F. Charbonneau, P. Ganz, A.P. Selwyn, and T.J. Anderson. 1996. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation. 93:457-162.
14. Suzuki, J., M. Aikawa, M. Isobe, M. Sekiguchi, Y. Yazaki, and R. Nagai. 1995. Altered expression of smooth muscle and nonmuscle myosin heavy chain isoforms in rejected hearts: a sensitive marker for acute rejection and graft coronary arteriosclerosis. Transplant. Proc. 27:578.
15. Aziz, S., T.O. McDonald, and H. Gohra. 1995. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. J. Heart Lung Transplant. 14:S123-S136.
16. Dusting, G.J., and P.S. Macdonald. 1995. Endogenous nitric oxide in cardiovascular disease and transplantation. Ann. Med. 27:395-406.
17. Tanaka, S., W. Kamiike, T. Ito, S. Nozaki, F. Uchikoshi, M. Miyata, S. Nakata, R. Shirakura, H. Matsuda, and E. Kumura. 1995. Evaluation of nitric oxide during acute rejection after heart transplantation in rats. Transplant. Proc. 27:576-577.
18. Devlin, J., R.M. Palmer, C.E. Gonde, J. O'Grady, N. Heaton, K.C. Tan, J.F. Martin, S. Moncada, and R. Williams. 1994. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation (Baltimore). 58: 592-595.
19. Yang, X., N. Chowdhury, B. Cai, J. Brett, C. Marboe, R.R. Sciacca, R.E. Michler, and P.J. Cannon. 1994. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J. Clin. Invest. 94:714-721.
20. Russell, M.E., A.F. Wallace, L.R. Wyner, J.B. Newell, and M.J. Karnovsky. 1995. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 92:457-464.
21. Radomski, M.W., R.M.J. Palmer, and S. Moncada. 1987. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:639-646.
22. Ignarro, L.J., G.M. Buga, K.S. Wood, R.E. Byrns, and G. Chaudhuri. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:9265-9269.
23. Worrall, N.K., W.D. Lazenby, T.P. Misko, T.S. Lin, C.P. Rodi, P.T. Manning, R.G. Tilton, J.R. Williamson, and T.B. Ferguson, Jr. 1995. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181:63-70.
24. Kubes, P., M. Suzuki, and D.N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:4651-4655.
25. Langrehr, J.M., R.A. Hoffman, T.R. Billiar, K.K. Lee, W.H. Schraut, and R.L. Simmons. 1991. Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. Surgery (St. Louis). 110:335-342.
26. von der Leyen, H.E., G.H. Gibbons, R. Morishita, N.P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J.P. Cooke, and V.J. Dzau. 1995. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA. 92:1137-1141.
27. Tzeng, E., L.L. Shears, M.T. Lotze, and T.R. Billiar. 1996. Gene therapy. Curr. Probl. Surg. 33:961-1041.
28. Tzeng, E., L.L. Shears, P.D. Robbins, B.R. Pitt, D.A. Geller, S.C. Watkins, R.L. Simmons, and T.R. Billiar. 1996. Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects of myointimal hyperplasia. Mol. Med. 2:211-225.
29. Akita, K., G.J. Dusting, and H. Hickey. 1994. Suppression of nitric oxide production by cyclosporine A and FK 506A in rat vascular smooth muscle cell. Clin. Exp. Pharmacol. Physiol. 21:231-233.
30. Marumo, T., T. Nakaki, K. Hishikawa, H. Suzuki, R. Kato, and T. Saruta. 1995. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension (Dallas). 25:764-768.
31. Kunz, D., G. Walker, W. Eberhardt, D. Nitsch, and J. Pfeilschifter. 1995. Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem. Biophys. Res. Commun. 216:438-446.
32. Hunley, T.E., S. Iwasaki, T. Homma, and V. Kon. 1995. Nitric oxide and endothelin in pathophysiological settings. Pediatr. Nephrol. 9:235-244.
33. Hayry, P., A. Mennander, S. Tiisala, J. Halttunen, S. Yilmaz, and T. Paavonen. 1991. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis. Transplant. Proc. 23:611-612.
34. 6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 37:3886-3888.
35. Hansson, G.K., Y.J. Geng. J. Holm, P. Hardhammer, A. Wennmalm, and E. Jennische. 1994. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med 180:733-738.
36. Geller, D.A., C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, S.C. Wang, D.K. Nakayama, S.H. Snyder, R.L. Simmons, and T.R. Billiar. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA. 90:3491-3495.
37. Graham, F.L., J. Smiley, W.C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from a human adenovirus type 5. J. Gen. Virol. 36:59-74.
38. Stow, N.D. 1981. Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. J. Virol. 37:171-180.
39. Geller, D.A., A.K. Nussler, M. Di Silvio, C.J. Lowenstein, R.A. Shapiro, S.C. Wang, R.L. Simmons, and T.R. Billiar. 1993. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA. 90:522-526.
40. Marks, D.S., J.A. Vita, J.D. Folts, J.F. Keaney, Jr., G.N. Welch, and J. Loscalzo. 1995. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest. 96:2630-2638.
41. Guo, J.P., K.A. Milhoan, R.S. Tuan, and A.M. Lefer. 1994. Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in a rat carotid artery intimai injury. Circ. Res. 75:77-84.
42. Lee, J.S., C. Adrie, H.J. Jacob, J.D. Roberts, Jr., W.M. Zapol, and K.D. Bloch. 1996. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ. Res. 78:337-342.
43. Lamas, S., P.A. Marsden, G.K. Li, P. Tempst, and T. Michel. 1992. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA. 89:6348-6352.
44. Nakayama, D.K., D.A. Geller, M. Di Silvio, G. Bloomgarden, P. Davies, B.R. Pitt, K. Hatakeyama, H. Kagamiyama, R.L. Simmons, and T.R. Billiar. 1994. Tetrahydrobiopterin synthesis and inducible nitric oxide production in pulmonary artery smooth muscle. Am. J. Physiol. 266:L455-L460.
45. Akyurek, L.M., B.C. Fellstrom, Z.Q. Yan, G.K. Hansson, K. Funa, and E. Larsson. 1996. Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic allografts. Am. J. Pathol. 149:1981-1990.
46. Schmidt, H.H., and U. Walter. 1994. NO at work. Cell. 78:919-925.
47. Newman, K.D., P.F. Dunn, J.W. Owens, A.H. Schulick, R. Virmani, G. Sukhova, P. Libby, and D.A. Dichek. 1995. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J. Clin. Invest. 96:2955-2965.
48. Jooss, K., Y. Yang, and J.M. Wilson. 1996. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7:1555-1566.